MicroRNAs as the critical regulators of Cisplatin resistance in ovarian cancer cells

被引:0
作者
Meysam Moghbeli
机构
[1] Mashhad University of Medical Sciences,Department of Medical Genetics and Molecular Medicine, School of Medicine
来源
Journal of Ovarian Research | / 14卷
关键词
Ovarian cancer; Chemo-resistance; Cisplatin; MicroRNA; Chemotherapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 276 条
[1]  
Siegel R(2013)Cancer statistics, 2013 CA Cancer J Clin 63 11-30
[2]  
Naishadham D(2011)Specific thiazolidinediones inhibit ovarian cancer cell line proliferation and cause cell cycle arrest in a PPARgamma independent manner PLoS One 6 938-948
[3]  
Jemal A(2012)Ovarian cancer risk factors by histologic subtypes in the NIH-AARP diet and health study Int J Cancer 131 111951-151
[4]  
Al-Alem L(2020)Potential cytotoxic and anti-metastatic effects of berberine on gynaecological cancers with drug-associated resistance Eur J Med Chem 187 119-437
[5]  
Yang HP(2015)microRNA and ovarian cancer Adv Exp Med Biol 889 427-281
[6]  
Mortazavi H(2017)Epidemiology and treatment patterns of epithelial ovarian cancer Expert Rev Anticancer Ther 17 626-725
[7]  
Langhe R(2016)Targeted agents in epithelial ovarian cancer: review on emerging therapies and future developments Ecancermedicalscience 10 275-147
[8]  
Jessmon P(2009)Platinum compounds 30 years after the introduction of cisplatin: implications for the treatment of ovarian cancer Gynecol Oncol 112 719-2065
[9]  
Lokadasan R(2011)Rethinking ovarian cancer: recommendations for improving outcomes Nat Rev Cancer 11 139-501
[10]  
Muggia F(2005)Role of chemotherapy in the management of epithelial ovarian cancer Expert Rev Anticancer Ther 5 2057-50